Yet despite multinational corporations investing large sums of money into R&D each year, the majority of their technologies remain uncommercialized, says Roland Austrup, Chief Growth Officer of Innventure (NASDAQ: INV).

In the high-stakes world of corporate innovation, these unrealized opportunities represent both a challenge and an untapped reservoir of value waiting for the right commercialization pathway. And this overlooked opportunity is what Innventure has built its entire business model around.

“We're not a venture capital firm or an incubator—we're founders and operators who build businesses that we believe have the potential to reach billion-dollar valuations,” says Austrup.

Innventure was founded by scientists and entrepreneurs who identify promising innovations in research labs, provide funding and entrepreneurial expertise, and then transform those opportunities into standalone companies as a solution to the innovation gap between corporate R&D and the marketplace.

Innventure aims to create high-growth businesses to help solve tomorrow’s biggest challenges—and so far, it’s making a meaningful impact.

The science of a systematic approach to company creation

Multinational corporations with substantial R&D investments are among the world's biggest investors in research and development, but the technologies they develop aren't always within their core focus.

All too often, promising technologies remain unrealized—not because they lack potential, but because of the realities of resource allocation or core competencies. For instance, a consumer goods company might develop a groundbreaking packaging material, or a telecommunications giant might create an innovative hardware solution.

Unlike traditional venture capital or private equity firms, which primarily provide funding and limited oversight, Innventure assembles complete company-building teams—from executives and technical experts to marketing and operations professionals—to found, fund, operate and scale selected opportunities. This operational intensity, combined with their systematic evaluation, creates what Austrup calls “the science of company creation”—a repeatable methodology for transforming corporate innovations into market-leading businesses.

Through a distinctive conglomerate structure, Innventure creates a unique economic engine where each new company contributes to potential long-term value creation. This model offers public market investors something rarely available elsewhere: exposure to multiple early-stage technology opportunities with the potentially reduced risk profile that comes from corporate validation and systematic evaluation.

As these individual companies address growing markets like data center cooling or sustainable packaging, the model aims to generate compounding returns from innovations that might otherwise remain unrealized. The strategy combines the potential upside of early-stage technology with the disciplined approach and reduced risk typically associated with more mature opportunities.